Literature DB >> 11869085

Local overexpression of adeno-viral IL-4 protects cartilage from metallo proteinase-induced destruction during immune complex-mediated arthritis by preventing activation of pro-MMPs.

P L E M van Lent1, A E M Holthuysen, A Slöetjes, E Lubberts, W B van den Berg.   

Abstract

OBJECTIVE: To determine whether IL-4 protects against metalloproteinase-induced cartilage destruction during immune complex mediated arthritis and to elucidate its mechanism.
METHODS: Experimental immune complex arthritis (ICA) was raised by injecting lysozyme into the knee joints of mice which previously were given anti-lysozyme antibodies. Three days before ICA induction, mice were injected into the right knee joint with either IL-4 expressing or empty control recombinant human type 5 adenovirus. Joint inflammation and cartilage destruction (PG depletion, erosion) was measured by histology of total knee joints. Aggrecan breakdown in cartilage caused by metalloproteinases (MMPs) was studied by immunolocalization using anti-VDIPEN antibodies.
RESULTS: Four days after ICA induction, histological analysis showed comparable exudate and infiltrate in both groups. Depletion of proteoglycans as measured by loss of red staining was also comparable in both groups. IL-4 treatment inhibited MMP-mediated neoepitope expression by 90%. Moreover, cartilage matrix erosion was evident in all animals (10 out of 10 mice) in the control group and significantly diminished (only two out of ten mice) in the IL-4 treated group. Incubation of patellae with APMA, which activates latent MMPs resulted in VDIPEN expression which was not significantly different from control ICA indicating that comparable amounts of latent pro-MMPs are present in IL-4 treated arthritic knee joints.
CONCLUSION: This study indicates that during ICA, IL-4 largely prevents MMP-mediated aggrecan breakdown and severe cartilage erosion. IL-4 does not inhibit production of latent MMPs by the chondrocyte but predominantly interferes with its activation. Copyright 2002 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869085     DOI: 10.1053/joca.2001.0501

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  13 in total

Review 1.  Platelet-Rich Plasma and Cartilage Repair.

Authors:  Mitchell I Kennedy; Kaitlyn Whitney; Thos Evans; Robert F LaPrade
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

2.  Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.

Authors:  W Hui; H E Barksby; D A Young; T E Cawston; N McKie; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

3.  Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.

Authors:  Teresa Hemmerle; Fabia Doll; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

4.  Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.

Authors:  Christine M De Nardo; Jason C Lenzo; Jarrad Pobjoy; John A Hamilton; Andrew D Cook
Journal:  Arthritis Res Ther       Date:  2010-10-25       Impact factor: 5.156

5.  Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis.

Authors:  Uta Schurigt; Nadine Stopfel; Marion Hückel; Christina Pfirschke; Bernd Wiederanders; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2004-12-10       Impact factor: 5.156

6.  Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro.

Authors:  Elisa Assirelli; Lia Pulsatelli; Paolo Dolzani; Daniela Platano; Eleonora Olivotto; Giuseppe Filardo; Giovanni Trisolino; Andrea Facchini; Rosa Maria Borzì; Riccardo Meliconi
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

7.  Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.

Authors:  Wouter Hofkens; Rik Schelbergen; Gert Storm; Wim B van den Berg; Peter L van Lent
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation.

Authors:  Karin C A M Nabbe; Peter L E M van Lent; Astrid E M Holthuysen; Annet W Sloëtjes; Alisa E Koch; Timothy R D J Radstake; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2005-01-26       Impact factor: 5.156

Review 9.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

10.  STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis.

Authors:  Krista Kuuliala; Antti Kuuliala; Riitta Koivuniemi; Hannu Kautiainen; Heikki Repo; Marjatta Leirisalo-Repo
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.